Indonesia Diabetes Care Devices Market Outlook to 2028

Indonesia Diabetes Care Devices Market Overview

The Indonesia Diabetes Care Devices Market is valued at USD 134 million, driven by a growing diabetes population, estimated at over 11 million individuals, and increasing demand for home-based diabetes care devices. The market is primarily driven by the prevalence of Type 2 diabetes, advancements in glucose monitoring technologies, and increasing awareness about diabetes management options.

Indonesia's dominant market regions include Java and Sumatra. Java, being the most populous island with a more developed healthcare infrastructure, leads in the adoption of diabetes care devices. The economic power of Jakarta, as well as other urban centers like Surabaya and Bandung, contributes to the high penetration of advanced diabetes devices.

In 2024, the Indonesian government allocated over IDR 15 trillion for the management and treatment of non-communicable diseases, including diabetes. This funding will be used to enhance healthcare infrastructure, procure more advanced diabetes care devices for public healthcare institutions, and subsidize treatments for low-income individuals.

Indonesia Diabetes Care Devices Market Segmentation

By Product Type: The market is segmented by product type into Blood Glucose Monitoring Devices and Insulin Delivery Devices. Among these, blood glucose monitoring devices hold a dominant share due to the rising number of diabetic patients and the widespread availability of self-monitoring devices, such as glucometers and test strips, which are highly demanded due to their cost-effectiveness and ease of use. In addition, the growing awareness about diabetes care and monitoring further supports the market growth in this segment.

By End User: The market is further segmented by end users into Hospitals and Homecare Settings. Hospitals are major end-users of diabetes care devices due to the high volume of in-patient treatments and specialized diabetes care services. However, the homecare setting segment is rapidly growing, driven by the increasing adoption of self-care management among diabetic patients, which allows them to monitor their condition effectively from the comfort of their homes.

Indonesia Diabetes Care Devices Market Competitive Landscape

The market is highly competitive, with major players including global manufacturers and local distributors. The market is dominated by companies like Medtronic, Roche, Abbott, and Novo Nordisk, all of which have established strong distribution networks and continuous product innovations to meet local needs.

Company

Year Established

Headquarters

Product Innovation

Strategic Partnerships

Market Presence

R&D Investment

Distribution Network

Customer Support

Medtronic

1949

Dublin, Ireland

Roche

1896

Basel, Switzerland

Abbott

1888

Chicago, USA

Novo Nordisk

1923

Bagsvrd, Denmark

Dexcom

1999

San Diego, USA

Indonesia Diabetes Care Devices Market Analysis

Market Growth Drivers

Increasing Prevalence of Diabetes: In 2024, Indonesia is projected to have over 10 million people living with diabetes, according to national health data. This growing patient base will drive the demand for diabetes care devices, including glucometers, insulin pens, and continuous glucose monitoring (CGM) systems.

Government Programs Supporting Diabetes Management: Indonesia's Ministry of Health has launched multiple initiatives, such as the Gerakan Masyarakat Hidup Sehat (Community Movement for Healthy Living), aimed at controlling non-communicable diseases like diabetes. In 2024, government expenditure on diabetes-related healthcare is projected to increase by over IDR 10 trillion, leading to a rise in healthcare infrastructure investments, including the procurement of diabetes care devices for public hospitals and clinics.

Growing Demand for Insulin Delivery Devices: As of 2024, over 2 million insulin-dependent diabetic patients are recorded in Indonesia. The rising number of insulin-dependent diabetics will lead to an increased need for devices such as insulin pens and insulin pumps. Hospitals and healthcare centers have started integrating more advanced delivery methods into patient care, with the Indonesian market seeing steady imports of such devices to meet the rising demand.

Market Challenges

High Cost of Advanced Devices: While basic glucose monitoring devices are affordable, advanced technologies like continuous glucose monitoring (CGM) systems and insulin pumps remain costly in Indonesia. In 2024, the average price of a CGM system is reported to be over IDR 4 million, which is out of reach for many middle- and lower-income families.

Lack of Awareness and Education: Despite the growing burden of diabetes in Indonesia, many individuals remain unaware of proper diabetes management techniques, including the use of care devices. In 2024, estimates show that over 30% of diabetic patients in Indonesia have not undergone regular blood sugar monitoring due to a lack of awareness.

Indonesia Diabetes Care Devices Market Future Outlook

Over the next five years, the Indonesia Diabetes Care Devices industry is expected to experience strong growth, driven by continuous advancements in diabetes care technology, a growing diabetic population, and increasing awareness about the benefits of self-care management.

Future Market Opportunities

Expansion of Local Production: Over the next five years, local production of diabetes care devices is expected to expand, reducing the countrys dependence on imported products. By 2029, local manufacturers are projected to produce over 1 million units of glucose monitors annually, driven by government incentives and increasing demand.

Growth in Telemedicine for Diabetes Management: Telemedicine is expected to play a larger role in Indonesias diabetes care market in the future. By 2029, over 200,000 diabetic patients are anticipated to use telemedicine platforms integrated with continuous glucose monitoring devices.
Please Note: It will take 5-7 business days to complete the report upon order confirmation